The impact of malaria is serious and getting worse throughout the world. Malaria remains a significant cause of death and illness among adults and children. Controlling of malaria needs an incorporated approach, comprising prompt treatment and prevention with effective antimalarial agents. Malaria is typically prevalent in hot climate. Anopheles mosquito, that transfers malaria parasite from one person to another, thrives in warm, moist climate where ponds of water offer it the perfect breeding platforms. Malaria is highly prevalent in conditions where health care systems are inadequate and awareness is low. Malaria is curable disease if effective treatment is initiated early. Delay in action may lead to severe implications, including death. Effective and prompt treatment is also important for controlling the spread of malaria. The cost of malaria is enormous for human and social being as the disease typically attacks not once but repeatedly into affected victims. The World Bank and the World Health Organization (WHO) rank malaria as the single largest factor of disease in Africa, causing disability and premature mortality.

Increase in government expenditure for prevention of malaria is a key driving factor for the malaria treatment market. According to the WHO, the estimated total funding for control and elimination of malaria was US$ 2.9 Bn in 2015. Moreover, in 2015, around 212 million cases of malaria were reported and 429,000 deaths were caused by malaria globally. Thus, high prevalence and disease burden of malaria are expected to drive the malaria treatment market during the forecast period.

The global malaria treatment market can be segmented depending on treatment type, route of administration, end-user, and geography. Based on treatment type, the global malaria treatment market can be categorized into vaccines, anti-malarial agents, diagnostic tests, and indicators. On the basis of route of administration, the malaria treatment market can be classified into oral, intravenous, and parenteral. Based on end-user, the global malaria treatment market can be divided into hospitals, specialty clinics, and others.

In terms of geography, the global malaria treatment market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Further, the malaria treatment market in North America can be bifurcated into the U.S. and Canada. The malaria treatment market in Europe can be divided into the U.K., Germany, France, Italy, Spain, and Rest of Europe. The malaria treatment market in Asia Pacific can be further classified into Japan, India, China, Australia & New Zealand, and Rest of Asia Pacific. Mexico, Brazil, and Rest of Latin America are the sub-segments of the malaria treatment market in Latin America, while the market in Middle East & Africa comprises Saudi Arabia, South Africa, Israel, and Rest of Middle East & Africa. Prevalence of malaria is higher in Asia Pacific and Middle East & Africa region as compared to that in North America and Europe. According to statistics published by the WHO in 2016, the highest number cases of malaria were detected in Asia Pacific and Middle East & Africa. It is estimated that 53% of the population in Middle East & Africa is at risk of malaria. According to the WHO, 58% of the cases of malaria caused by P. vivax occurs in Asia Pacific, followed by Middle East & Africa. Moreover, around 76% of the registered cases of malaria in 2015 were from just 13 countries. India, Ethiopia, Pakistan, and Indonesia accounted for high prevalence of malaria due to P. vivax.

Some of the key players operating in malaria treatment market are Novartis AG, Pfizer, Inc., Amyris,  GlaxoSmithKline, Concordia International Corp., Lannett Company, Inc.,  Mylan Pharmaceuticals Inc., Teva Pharmaceuticals, Inc., Fresenius Kabi, LLC, Roxane Laboratories, Inc., Baxter International Inc., and Sanofi.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Malaria Treatment Market

Pre Book